We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Company Publishes Study Comparing Biosimilar, Brand
Company Publishes Study Comparing Biosimilar, Brand
September 4, 2007
More than a year after the European Commission (EC) approved Valtropin, a biosimilar recombinant human growth hormone (rhGH) product, results of a pivotal Phase III trial comparing Valtropin with the reference product are being published, Biopartners announced.